Correlation Between Neurocrine Biosciences and Auxly Cannabis

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Auxly Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Auxly Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Auxly Cannabis Group, you can compare the effects of market volatilities on Neurocrine Biosciences and Auxly Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Auxly Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Auxly Cannabis.

Diversification Opportunities for Neurocrine Biosciences and Auxly Cannabis

-0.51

Correlation Coefficient

Neurocrine Biosciences  Auxly Cannabis

Excellent diversification

The 3 months correlation between Neurocrine and Auxly is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Auxly Cannabis Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Auxly Cannabis Group and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Auxly Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Auxly Cannabis Group has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Auxly Cannabis go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Auxly Cannabis

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.22 times more return on investment than Auxly Cannabis. However, Neurocrine Biosciences is 4.49 times less risky than Auxly Cannabis. It trades about 0.27 of its potential returns per unit of risk. Auxly Cannabis Group is currently generating about 0.03 per unit of risk. If you would invest  12,544  in Neurocrine Biosciences on October 4, 2024 and sell it today you would earn a total of  1,106  from holding Neurocrine Biosciences or generate 8.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Auxly Cannabis Group

Neurocrine Biosciences

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Auxly Cannabis Group

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Auxly Cannabis Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Auxly Cannabis may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Neurocrine Biosciences and Auxly Cannabis

The main advantage of trading using opposite Neurocrine Biosciences and Auxly Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Auxly Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auxly Cannabis will offset losses from the drop in Auxly Cannabis' long position.

The idea behind Neurocrine Biosciences and Auxly Cannabis Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.